Cabaletta Bio (CABA) Cash from Financing Activities (2018 - 2025)

Cabaletta Bio's Cash from Financing Activities history runs 8 years deep, the most recent figure standing at $8.3 million for Q4 2025.

• In Q4 2025, Cash from Financing Activities rose 90.58% year-over-year to $8.3 million; the TTM figure through Dec 2025 stood at $100.3 million (up 759.36% YoY), while the FY2025 annual figure was $100.3 million, up 759.36% from the prior year.
• Cash from Financing Activities was $8.3 million for Q4 2025 at Cabaletta Bio, up from -$806000.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $94.3 million in Q2 2023 to a low of -$806000.0 in Q3 2025.
• Historically, Cash from Financing Activities has averaged $20.1 million across 5 years, with a median of $4.4 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities surged 235545.0% in 2023, then slumped 1235.21% in 2025.
• A 5-year view of Cash from Financing Activities shows it stood at $13.6 million in 2021, then soared by 141.35% to $32.9 million in 2022, then jumped by 182.9% to $93.0 million in 2023, then sank by 95.3% to $4.4 million in 2024, then soared by 90.58% to $8.3 million in 2025.
• The last three Cash from Financing Activities figures came in at $8.3 million (Q4 2025), -$806000.0 (Q3 2025), and $93.4 million (Q2 2025), per Business Quant data.